CLAUVIAX 156MG/5ML SUSPENSION
CLAUVIAX 156MG/5ML SUSPENSION
What it does
Clauviax is a medication used to treat various conditions.
Commonly used for: bacterial infections, infections caused by certain bacteria
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.
Source this medicineRegistration & product details
Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:07:04 · updated 2026-08-03 04:07:19
About this medicine
Clauviax is a medication used to treat various conditions.
What it treats
- bacterial infections
- infections caused by certain bacteria
How it works
Clauviax works by stopping the growth of bacteria, helping to clear the infection.
Who it's for
This medication is for adults and children who have infections that can be treated with antibiotics.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: clauviax
Clauviax is an antibiotic medication used primarily for the treatment of bacterial infections. It belongs to the class of drugs known as beta-lactam antibiotics, which work by inhibiting bacterial cell wall synthesis. This action leads to the lysis and death of susceptible bacteria, making it effective against a variety of gram-positive and some gram-negative organisms.
Indications
- Bacterial infections
- Pneumonia
- Urinary tract infections
- Skin and soft tissue infections
- Sinusitis
- Otitis media
Dosage
Children: Refer to the BNF for Children for appropriate dosing based on age, weight, and clinical condition.
Adults: Refer to established clinical guidelines or the relevant BNF for specific dosing recommendations based on the type and severity of the infection.
Mechanism of action
Clauviax exerts its antibacterial effect by binding to penicillin-binding proteins (PBPs) located inside the bacterial cell wall. This binding inhibits the transpeptidation enzyme that is critical for cross-linking peptidoglycan layers, ultimately resulting in a weakened cell wall and cell lysis. The disruption of cell wall synthesis is a key factor in the bactericidal activity of Clauviax.
Pharmacodynamics
The pharmacodynamic profile of Clauviax indicates that its effectiveness is dependent on the time that the free antibiotic concentration remains above the minimum inhibitory concentration (MIC) for the target organism. The drug shows a time-dependent killing effect, meaning that prolonged exposure to the antibiotic correlates with enhanced antibacterial activity. Resistance mechanisms, such as the production of beta-lactamases, can diminish the efficacy of Clauviax against certain bacterial strains.
Pharmacokinetics
Clauviax is typically well absorbed when administered orally, with peak plasma concentrations occurring within 1 to 2 hours after ingestion. The drug is widely distributed throughout the body, including into tissues and fluids. Metabolism occurs in the liver, and it is primarily eliminated through the kidneys. The half-life of Clauviax varies, but it is generally within the range of 1 to 3 hours, necessitating multiple doses throughout the day for sustained therapeutic effect.
Pregnancy
Clauviax should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus.
Breast-feeding
It is not known whether Clauviax is excreted in human milk. Caution should be exercised when administering to breastfeeding women.
Storage
Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.